Quarterly report pursuant to Section 13 or 15(d)

Prepaid Expenses and Other Current Assets

v3.21.2
Prepaid Expenses and Other Current Assets
9 Months Ended
Sep. 30, 2021
Prepaid Expense And Other Assets Current [Abstract]  
Prepaid Expenses and Other Current Assets

5. Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following:

 

 

 

September 30,

2021

 

 

December 31,

2020

 

Refundable FDA filing fee (1)

 

$

—

 

 

$

2,876

 

Short-term deposits

 

 

2,293

 

 

 

2,360

 

Prepaid insurance

 

 

954

 

 

 

415

 

Research and development tax credit receivable

 

 

877

 

 

 

801

 

Interest receivable

 

 

136

 

 

 

—

 

Other prepaid assets

 

 

132

 

 

 

231

 

Prepaid research and development expenses

 

 

51

 

 

 

157

 

Value added tax receivable

 

 

14

 

 

 

64

 

Deferred financing expenses

 

 

45

 

 

 

—

 

Total

 

$

4,502

 

 

$

6,904

 

(1) FDA filing fee refund of $2,876 was received in January 2021